Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/12860219
Conclusion of this study
There was a significant decrease in mortality in the berberine-treated patients during long-term follow-up (7 patients receiving treatment died vs 13 on placebo, p <0.02). Proarrhythmia was not observed, and there were no apparent side effects. Thus, berberine improved quality of life and decreased VPCs and mortality in patients with CHF.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study